Inventurus Knowledge Solutions (IKS Healthcare), backed by the family of late investor Rakesh Jhunjhunwala, is in advanced discussions to acquire Nasdaq-listed TruBridge for approximately $600 million, according to sources familiar with the matter. If finalised, the deal would mark IKS’s largest acquisition to date and significantly strengthen its foothold in the healthcare solutions and revenue cycle management (RCM) space. A formal announcement is expected soon.
The potential acquisition comes amid heightened investor interest and rapid consolidation in the healthcare RCM sector over the past two years. IKS Healthcare, which delivered a remarkable 530-fold return to the Jhunjhunwala family following its December 2024 listing, is primarily owned by three family trusts Nishtha, Aryavir, and Aryaman each holding 16.37%. Rekha Jhunjhunwala owns an additional 0.23%, while founder Sachin Gupta holds 33.57%, taking the total promoter stake to 63.7%.
Founded in 2006 as an RCM service provider, IKS Healthcare works closely with US healthcare providers, managing administrative and care-related processes such as scheduling, documentation, and denial management. The company expanded its capabilities with the $200 million acquisition of Aquity Solutions in October 2023, which added transcription services and brought in new client relationships.
To fund the TruBridge deal, IKS is reportedly in talks to raise around $675 million from major global lenders including Citi, Deutsche Bank, and JPMorgan. The financing would support the all-cash acquisition as well as refinancing of TruBridge’s existing debt.
TruBridge provides healthcare IT solutions and services to community hospitals and healthcare organisations in the US. For the 12 months ending December, the company reported revenue of $346.8 million, up from $342.2 million a year earlier, and posted a profit of $4.4 million compared to a loss of $20.9 million previously. Despite a slight revenue miss in its latest quarterly results, analysts remain cautiously optimistic about its turnaround prospects.
The broader healthcare RCM market continues to grow, driven by increasing complexity in billing and reimbursement systems, a stronger focus on patient experience, and the need for cost-efficient operations. Analysts note that IKS is leveraging artificial intelligence to improve efficiency, with revenue growing 18.3% year-on-year in Q3 FY26 while headcount increased by just 1.5%, indicating improved scalability.
The company is expected to continue investing around 5% of its revenue in research and development, focusing on enhancing its platform capabilities and competing with standalone service providers. With the US healthcare outsourcing market growing at about 12% annually, IKS aims to outpace this rate and gain market share.
Looking ahead, IKS plans to prioritise growth through acquisitions and reduce its remaining $50 million debt. Industry experts believe the company is well-positioned to pursue further consolidation opportunities across India and the US, particularly targeting underperforming assets that can deliver operational synergies.
The RCM sector has seen several major deals recently, including acquisitions by Blackstone, Ontario Teachers’ Pension Plan, TA Associates, EQT Partners, and Carlyle, reflecting strong investor appetite and ongoing consolidation in the space.